|
![]() |
|||
|
||||
OverviewThe development of new drugs for the treatment of cancer is both medically important and scientifically challenging. The monograph looks at some of the most exciting prospects, e.g., future clinilcal trials, new biological discoveries, and advances in molecular biology. This volume will be of interest to laboratory scientists in the academic sector and the pharmaceutical industry, as well as to medical professionals. The particalar topic covered are: - Experimental models to investigate novel anticancer drugs - Principles in the design of DNA-interactive molecules - Discovery of improved platinum analogues - Pharmacological intervention with signal transduction - Discovery, and design of inhibitors of oncogenic tyrosine kinases. Apoptosis and cancer therapy - Engineering antibodies for targeted cancer therapy Full Product DetailsAuthor: Paul WorkmanPublisher: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Imprint: Springer-Verlag Berlin and Heidelberg GmbH & Co. K Weight: 0.680kg ISBN: 9783540581536ISBN 10: 3540581537 Pages: 104 Publication Date: 04 November 1994 Audience: College/higher education , Professional and scholarly , Postgraduate, Research & Scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Out of stock ![]() The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |